BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

961 related articles for article (PubMed ID: 25341935)

  • 1. Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.
    Gilabert-Oriol R; Weng A; Mallinckrodt Bv; Melzig MF; Fuchs H; Thakur M
    Curr Pharm Des; 2014; 20(42):6584-643. PubMed ID: 25341935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribosome-Inactivating Proteins from Plants: A Historical Overview.
    Bolognesi A; Bortolotti M; Maiello S; Battelli MG; Polito L
    Molecules; 2016 Nov; 21(12):. PubMed ID: 27898041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in research on ribosome inactivating proteins.
    Ng TB; Wong JH; Wang H
    Curr Protein Pept Sci; 2010 Feb; 11(1):37-53. PubMed ID: 20201806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dianthin and Its Potential in Targeted Tumor Therapies.
    Fuchs H
    Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31614697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of Plant-Derived Ribosome Inactivating Proteins in Immunotoxin Development: Past, Present and Future Generations.
    Rust A; Partridge LJ; Davletov B; Hautbergue GM
    Toxins (Basel); 2017 Oct; 9(11):. PubMed ID: 29076988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of ribosome-inactivating proteins from Sambucus for the construction of immunotoxins and conjugates for cancer therapy.
    Ferreras JM; Citores L; Iglesias R; Jiménez P; Girbés T
    Toxins (Basel); 2011 May; 3(5):420-41. PubMed ID: 22069717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotoxins and other conjugates containing saporin-s6 for cancer therapy.
    Polito L; Bortolotti M; Pedrazzi M; Bolognesi A
    Toxins (Basel); 2011 Jun; 3(6):697-720. PubMed ID: 22069735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for the clinical use of immunotoxins: monoclonal antibodies conjugated to ribosome-inactivating proteins.
    Preijers FW
    Leuk Lymphoma; 1993 Mar; 9(4-5):293-304. PubMed ID: 8348066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribosome-inactivating and related proteins.
    Schrot J; Weng A; Melzig MF
    Toxins (Basel); 2015 May; 7(5):1556-615. PubMed ID: 26008228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Highly toxic type Ⅱ ribosome-inactivating proteins ricin and abrin and their detection methods: a review].
    Liang L; Xia J; Liu C; Liu S
    Se Pu; 2021 Mar; 39(3):260-270. PubMed ID: 34227307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to Improve the Clinical Utility of Saporin-Based Targeted Toxins.
    Giansanti F; Flavell DJ; Angelucci F; Fabbrini MS; Ippoliti R
    Toxins (Basel); 2018 Feb; 10(2):. PubMed ID: 29438358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosome-inactivating proteins: from plant defense to tumor attack.
    de Virgilio M; Lombardi A; Caliandro R; Fabbrini MS
    Toxins (Basel); 2010 Nov; 2(11):2699-737. PubMed ID: 22069572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new age for biomedical applications of Ribosome Inactivating Proteins (RIPs): from bioconjugate to nanoconstructs.
    Pizzo E; Di Maro A
    J Biomed Sci; 2016 Jul; 23(1):54. PubMed ID: 27439918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the uses and applications of ribosome-inactivating proteins from plants.
    Girbés T; Ferreras JM; Iglesias R; Citores L; De Torre C; Carbajales ML; Jiménez P; De Benito FM; Muñoz R
    Cell Mol Biol (Noisy-le-grand); 1996 Jun; 42(4):461-71. PubMed ID: 8828901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel adenine-releasing assay for ribosome-inactivating proteins.
    Weng A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():300-304. PubMed ID: 29202361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Protein Toxin Delivery Based on ATTEMPTS Systems.
    Chen Y; Zhang M; Min KA; Wang H; Shin MC; Li F; Yang VC; Huang Y
    Curr Drug Targets; 2018 Feb; 19(4):380-392. PubMed ID: 28260497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice.
    Terenzi A; Bolognesi A; Pasqualucci L; Flenghi L; Pileri S; Stein H; Kadin M; Bigerna B; Polito L; Tazzari PL; Martelli MF; Stirpe F; Falini B
    Br J Haematol; 1996 Mar; 92(4):872-9. PubMed ID: 8616080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small structural differences of targeted anti-tumor toxins result in strong variation of protein expression.
    Gilabert-Oriol R; Thakur M; Weise C; Dernedde J; von Mallinckrodt B; Fuchs H; Weng A
    Protein Expr Purif; 2013 Sep; 91(1):54-60. PubMed ID: 23867360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New ribosome-inactivating proteins and other proteins with protein synthesis-inhibiting activities.
    Wong JH; Bao H; Ng TB; Chan HHL; Ng CCW; Man GCW; Wang H; Guan S; Zhao S; Fang EF; Rolka K; Liu Q; Li C; Sha O; Xia L
    Appl Microbiol Biotechnol; 2020 May; 104(10):4211-4226. PubMed ID: 32193575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of anti-cancer immunotoxins in algae: ribosome inactivating proteins as fusion partners.
    Tran M; Henry RE; Siefker D; Van C; Newkirk G; Kim J; Bui J; Mayfield SP
    Biotechnol Bioeng; 2013 Nov; 110(11):2826-35. PubMed ID: 23719862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.